Gene · 5552
Papers1,669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Establishment of a novel indicator of pyroptosis regulated gene transcription level and its application in pan-cancer. | Sci Rep | 2023 | 37863886 | PubTator, text mining | PubMed |
| Thyroid transcription factor-1 (TTF-1) expression and the efficacy of combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapy in non-squamous non-small cell lung cancer. | Transl Lung Cancer Res | 2023 | 37854151 | PubTator, text mining | PubMed |
| Pyroptosis-related gene signatures are associated with prognosis and tumor microenvironment infiltration in head and neck cancer. | Health Sci Rep | 2023 | 37841942 | PubTator, text mining | PubMed |
| A Narrative Review on CD44's Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence. | Cancers (Basel) | 2023 | 37835592 | PubTator, text mining | PubMed |
| Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension. | Int J Mol Sci | 2023 | 37834471 | PubTator, text mining | PubMed |
| Linking Mechanisms of Vitamin D Signaling with Multiple Sclerosis. | Cells | 2023 | 37830605 | PubTator, text mining | PubMed |
| Erasure conversion in a high-fidelity Rydberg quantum simulator. | Nature | 2023 | 37821592 | PubTator, text mining | PubMed |
| Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients. | Neurooncol Adv | 2023 | 37811539 | PubTator, text mining | PubMed |
| Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line. | PLoS One | 2023 | 37768997 | PubTator, text mining | PubMed |
| Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 Inhibitors. | Nutrients | 2023 | 37764768 | PubTator, text mining | PubMed |
| Identification of Candidate Biomarkers of Alzheimer's Disease via Multiplex Cerebrospinal Fluid and Serum Proteomics. | Int J Mol Sci | 2023 | 37762527 | PubTator, text mining | PubMed |
The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour. | Int J Mol Sci | 2023 | 37762403 | PubTator, text mining | PubMed |
| Exploring the Transcriptome Dynamics of In Vivo Theileria annulata Infection in Crossbred Cattle. | Genes (Basel) | 2023 | 37761803 | PubTator, text mining | PubMed |
| Modulation of lytic molecules restrain serial killing in γδ T lymphocytes. | Nat Commun | 2023 | 37758698 | PubTator, text mining | PubMed |
| Identification of pyroptosis-related subtypes and comprehensive analysis of characteristics of the tumor microenvironment infiltration in clear cell renal cell carcinoma. | Sci Rep | 2023 | 37749171 | PubTator, text mining | PubMed |
| Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies. | Diabetes Ther | 2023 | 37736787 | PubTator, text mining | PubMed |
| Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology. | J Cancer Res Clin Oncol | 2023 | 37733241 | PubTator, text mining | PubMed |
| Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning. | Front Genet | 2023 | 37732314 | PubTator, text mining | PubMed |
| Transcriptome analysis of six tissues obtained post-mortem from sepsis patients. | J Cell Mol Med | 2023 | 37731199 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing revealed the molecular characteristics and prognostic roles of neutrophils in pancreatic cancer. | Aging (Albany NY) | 2023 | 37728418 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5552/papers?page=9